Evidence map›Paper›PMID 39820717›Full record

ArticleArchives of dermatological research2025

Differences in time to surgery and defect sizes after Mohs micrographic surgery for black versus white patients with cutaneous squamous cell carcinoma.

Karla L Valdes-Morales, Daniela Frankel, Mara Trifoi, Cory Shoshany, Kiara Corcoran Ruiz, Christopher J Miller, Jeremy R Etzkorn, Ramone F Williams, Jocelyn He, Gui-Shuang Ying and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karla L Valdes-MoralesDepartment of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Daniela FrankelDepartment of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Mara TrifoiDepartment of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Cory ShoshanyPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kiara Corcoran RuizDepartment of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Christopher J MillerDepartment of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Jeremy R EtzkornDepartment of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Ramone F WilliamsDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
Jocelyn HeDepartment of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gui-Shuang YingDepartment of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
César A BriceñoDepartment of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cesar.briceno@pennmedicine.upenn.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few studies have examined outcomes for Mohs micrographic surgery (MMS) for cutaneous squamous cell carcinoma (cSCC) in Black versus White patients. We compared time to surgery and defect sizes after MMS between Black versus White patients with cSCC. Patients with biopsy-proven cSCC treated with MMS at the Hospital of the University of Pennsylvania were identified from a prospectively maintained database (2006-2023). Our primary outcomes included time to surgery (days from the diagnostic biopsy to the first MMS) and defect size (final MMS defect surface area). Univariate and multivariate linear regression models were performed to compare outcomes between Black and White patients with adjustments for age, gender, and tumor location. We identified 8445 cSCC, including 8329 (98.2%) in White patients and 116 (1.4%) in Black patients. Mean time to surgery was 31% longer for Black (76 ± 3.9 days) versus White patients (58 ± 0.5 days) [p < 0.001]. Mean post-MMS cSCC defect size was nearly four times larger for Black (18.6 ± 1.2 cm

Indexed as

Black or African AmericanCarcinoma, Squamous CellMohs SurgerySkin NeoplasmsTime-to-TreatmentWhiteAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesSkinTreatment OutcomeKeratinocyte carcinomaMohs micrographic surgeryRacial disparitiesSkin of colorSquamous cell carcinoma

Identifiers

PMID39820717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.